Literature DB >> 21423145

One-year results of intravitreal bevacizumab as an adjunct to trabeculectomy for neovascular glaucoma in eyes with previous vitrectomy.

A Miki, Y Oshima, Y Otori, K Matsushita, K Nishida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21423145      PMCID： PMC3171263          DOI： 10.1038/eye.2011.58

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  5 in total

1.  Efficacy of intravitreal bevacizumab as adjunctive treatment with pars plana vitrectomy, endolaser photocoagulation, and trabeculectomy for neovascular glaucoma.

Authors:  A Miki; Y Oshima; Y Otori; M Kamei; Y Tano
Journal:  Br J Ophthalmol       Date:  2008-10       Impact factor: 4.638

2.  Trabeculectomy with mitomycin C for treatment of neovascular glaucoma in diabetic patients.

Authors:  Yoshiaki Kiuchi; Reiko Sugimoto; Kazuto Nakae; Yoshihiro Saito; Shigeo Ito
Journal:  Ophthalmologica       Date:  2006       Impact factor: 3.250

3.  Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma.

Authors:  Yoshiaki Saito; Tomomi Higashide; Hisashi Takeda; Shinji Ohkubo; Kazuhisa Sugiyama
Journal:  Acta Ophthalmol       Date:  2009-09-23       Impact factor: 3.761

4.  Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma.

Authors:  Naris Kitnarong; Panida Chindasub; Ankana Metheetrairut
Journal:  Adv Ther       Date:  2008-05       Impact factor: 3.845

5.  Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure.

Authors:  Yuji Takihara; Masaru Inatani; Mikiko Fukushima; Keiichiro Iwao; Minako Iwao; Hidenobu Tanihara
Journal:  Am J Ophthalmol       Date:  2009-02-05       Impact factor: 5.258
  5 in total
  7 in total

Review 1.  Anti-vascular endothelial growth factor for neovascular glaucoma.

Authors:  Arathi Simha; Andrew Braganza; Lekha Abraham; Prasanna Samuel; Kristina Lindsley
Journal:  Cochrane Database Syst Rev       Date:  2013-10-02

2.  Efficacy and safety of intravitreal ranibizumab with panretinal photocoagulation followed by trabeculectomy compared with Ahmed glaucoma valve implantation in neovascular glaucoma.

Authors:  Jin-Tao Sun; Hai-Jing Liang; Meng An; Da-Bo Wang
Journal:  Int J Ophthalmol       Date:  2017-03-18       Impact factor: 1.779

3.  Pharmacokinetics of intravitreally injected bevacizumab in vitrectomized eyes.

Authors:  Jeeyun Ahn; Hyuncheol Kim; Se Joon Woo; Ji Hyun Park; Sunyoung Park; Duck Jin Hwang; Kyu Hyung Park
Journal:  J Ocul Pharmacol Ther       Date:  2013-06-04       Impact factor: 2.671

Review 4.  Anti-vascular endothelial growth factor for neovascular glaucoma.

Authors:  Arathi Simha; Kanza Aziz; Andrew Braganza; Lekha Abraham; Prasanna Samuel; Kristina B Lindsley
Journal:  Cochrane Database Syst Rev       Date:  2020-02-06

5.  Long-Term Outcomes and Prognostic Factors of Trabeculectomy following Intraocular Bevacizumab Injection for Neovascular Glaucoma.

Authors:  Tomomi Higashide; Shinji Ohkubo; Kazuhisa Sugiyama
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

6.  25-gauge microincision vitrectomy to treat vitreoretinal disease in glaucomatous eyes after trabeculectomy.

Authors:  Hiroshi Kunikata; Naoko Aizawa; Nobuo Fuse; Toshiaki Abe; Toru Nakazawa
Journal:  J Ophthalmol       Date:  2014-04-22       Impact factor: 1.909

7.  Anti-VEGF Agents and Glaucoma Filtering Surgery.

Authors:  Ramin Daneshvar
Journal:  J Ophthalmic Vis Res       Date:  2013-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.